Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Nicolas Boursiquot

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Immunology Research|March 15, 2024
The Disease Burden of Hereditary Angioedema: Insights from a Survey in French-Canadians from QuebecJean-Nicolas Boursiquot, Hugo Chapdelaine, Charles St-Pierre, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 16, 2024
Allergen immunotherapyJean-Nicolas Boursiquot, Rémi Gagnon, Jaclyn Quirt, et al.
International Journal of Emergency Medicine|March 30, 2022
Bradykinin-induced angioedema in the emergency departmentJacques Hébert, Jean-Nicolas Boursiquot, Hugo Chapdelaine, et al.
Advances in Therapy|November 22, 2023
A Patient Charter for Chronic UrticariaMarcus Maurer, Mónica Albuquerque, Jean-Nicolas Boursiquot, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 28, 2024
Real-world outcomes of patients with hereditary angioedema with normal C1-inhibitor function and patients with idiopathic angioedema of unknown etiology in CanadaAdil Adatia, Jean-Nicolas Boursiquot, Dawn Goodyear, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 4, 2024
Safety of Direct Drug Provocation for the Evaluation of Penicillin Allergy in Low-Risk AdultsFrédéric Brillant-Marquis, Émilie Proulx, Kayadri Ratnarajah, et al.
Journal of Clinical Immunology|September 19, 2012
Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patientsJean-Nicolas Boursiquot, Laurence Gérard, Marion Malphettes, et al.
The Journal of Allergy and Clinical Immunology|November 2, 2015
Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-CanadiansChristina Gavino, Nancy Hamel, Ji Bin Zeng, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 3, 2019
The International/Canadian Hereditary Angioedema GuidelineStephen Betschel, Jacquie Badiou, Karen Binkley, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 14, 2020
Correction to: The International/Canadian Hereditary Angioedema GuidelineStephen Betschel, Jacquie Badiou, Karen Binkley, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Immunology Research|March 15, 2024
The Disease Burden of Hereditary Angioedema: Insights from a Survey in French-Canadians from QuebecJean-Nicolas Boursiquot, Hugo Chapdelaine, Charles St-Pierre, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 16, 2024
Allergen immunotherapyJean-Nicolas Boursiquot, Rémi Gagnon, Jaclyn Quirt, et al.
International Journal of Emergency Medicine|March 30, 2022
Bradykinin-induced angioedema in the emergency departmentJacques Hébert, Jean-Nicolas Boursiquot, Hugo Chapdelaine, et al.
Advances in Therapy|November 22, 2023
A Patient Charter for Chronic UrticariaMarcus Maurer, Mónica Albuquerque, Jean-Nicolas Boursiquot, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 28, 2024
Real-world outcomes of patients with hereditary angioedema with normal C1-inhibitor function and patients with idiopathic angioedema of unknown etiology in CanadaAdil Adatia, Jean-Nicolas Boursiquot, Dawn Goodyear, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 4, 2024
Safety of Direct Drug Provocation for the Evaluation of Penicillin Allergy in Low-Risk AdultsFrédéric Brillant-Marquis, Émilie Proulx, Kayadri Ratnarajah, et al.
Journal of Clinical Immunology|September 19, 2012
Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patientsJean-Nicolas Boursiquot, Laurence Gérard, Marion Malphettes, et al.
The Journal of Allergy and Clinical Immunology|November 2, 2015
Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-CanadiansChristina Gavino, Nancy Hamel, Ji Bin Zeng, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 3, 2019
The International/Canadian Hereditary Angioedema GuidelineStephen Betschel, Jacquie Badiou, Karen Binkley, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 14, 2020
Correction to: The International/Canadian Hereditary Angioedema GuidelineStephen Betschel, Jacquie Badiou, Karen Binkley, et al.
Pageof 2